is the single preventable cause of death as against
the top five factors for mortality.
Globally, smoking is an important cause of mortality and morbidity. It
is unanimously accepted as the main cause of cardiovascular and metabolic
disease. Since the sensitivity to insulin is reduced and insulin resistance is
increased by smoking so the risk of cardiovascular disease is also enhanced.
Smoking elevates plasma triglycerides
, causes hypoglycemia
high-density lipoprotein cholesterol. Researchers have revealed that smoking is
often related with rise in risk of Metabolic Syndrome and metabolic anomalies
Hellas Cena and colleagues conducted a cross-sectional study that was
published in BMC, to assess the prevalence of Metabolic Syndrome among smokers.
The scientist enrolled people in age group of 28 to 70
years and who were smoking since last 10 years.
They joined the smoking cessation program held by the Respiratory
Pathophysiology Unit of San Matteo Hospital, Pavia, Northern Italy.
The volunteers did not have any history of diabetes or coronary artery
disease or heart disease (CVD).
The researchers observed that the occurrence of metabolic syndrome was
53.1 percent of which 44.9 percent were in females and 57.3 percent in males
Rise in variables such as systolic blood pressure, HDL
cholesterol and fasting plasma glucose levels was noted in light and heavy
Finally the researchers advocated that smokers are
predisposed to a high threat of metabolic syndrome. They said that proactive interventions are needed to
encourage smokers to quit smoking.
Prevalence rate of Metabolic Syndrome in a group of
light and heavy smokers; Hellas Cena et al; BMC Diabetology and Metabolic